LGM
IDYA icon

Logos Global Management’s IDEAYA Biosciences IDYA Stock Holding History

Logos Global Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-450,000
Closed -$15.6M – 72
2025
Q4 		$15.6M Hold
450,000
– – 0.94% 34
2025
Q3 		$12.2M Buy
+450,000
New +$10.9M 1.1% 34

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Logos Global Management's IDYA Position: Q1 2026 in Review

Logos Global Management increased its IDEAYA Biosciences (IDYA) stake by 10% in Q1 2026, buying an estimated $10.9M and bringing the position to 3,450,000 shares worth $115M. The position accounts for 5.74% of the portfolio, ranked #3.

Logos Global Management first reported a position in IDYA in Q3 2021 and has held it in 19 quarters since. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Logos Global Management held 3,450,000 shares of IDEAYA Biosciences worth $115M as of Q1 2026.
  • Logos Global Management bought 325,000 IDEAYA Biosciences shares in Q1 2026, an estimated $10.9M.
  • IDEAYA Biosciences made up 5.74% of Logos Global Management's portfolio in Q1 2026, its #3 holding.
  • Logos Global Management first reported a position in IDEAYA Biosciences in Q3 2021 and has held it in 19 quarters since.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Logos Global Management's 13F filing for Q1 2026, filed 15 May 2026.